Photocure 
PHO presented Q3 numbers with top line numbers just a hint weaker than consensus, but with the strongest quarterly growth rate in deployed cystoscopes ever noted.
The stock is currently trading above earlier support, and a move through NOK 60 could trigger a strong BUY signal.
Q3 Report:
https://photocure.com/globalassets/investor-relations/quarterly-reports/2019/pho-q3-2019-rep.pdf
Q3 webcast in english with CEO Daniel Schneider of Photocure:
https://webtv.hegnar.no/presentation.php?webcastId=98164404
PHO presented Q3 numbers with top line numbers just a hint weaker than consensus, but with the strongest quarterly growth rate in deployed cystoscopes ever noted. The stock is currently trading above earlier support, and a move through NOK 60 could trigger a strong BUY signal.
Q3 Report:
https://photocure.com/globalassets/investor-relations/quarterly-reports/2019/pho-q3-2019-rep.pdf
Q3 webcast in english with CEO Daniel Schneider of Photocure:
https://webtv.hegnar.no/presentation.php?webcastId=98164404
면책사항
이 정보와 게시물은 TradingView에서 제공하거나 보증하는 금융, 투자, 거래 또는 기타 유형의 조언이나 권고 사항을 의미하거나 구성하지 않습니다. 자세한 내용은 이용 약관을 참고하세요.
면책사항
이 정보와 게시물은 TradingView에서 제공하거나 보증하는 금융, 투자, 거래 또는 기타 유형의 조언이나 권고 사항을 의미하거나 구성하지 않습니다. 자세한 내용은 이용 약관을 참고하세요.